Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

ClinicalTrials.gov ID: NCT00320710

Public ClinicalTrials.gov record NCT00320710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in in the 2nd Year of Treatment in Patients With Documented Bone Metastases From Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Clinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen. Looking at the continued effectiveness and safety of giving zoledronic acid every 4 weeks versus every 12 weeks given over 1 year. This study is prospective, double-blind, stratified, multi-center, and two-arm.

Study identification

NCT ID
NCT00320710
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
416 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Jul 2013 (Actual)
Completion
Jul 2013 (Actual)
Last update posted
Aug 22, 2014

2006 – 2013

United States locations

U.S. sites
92
U.S. states
32
U.S. cities
84
Facility City State ZIP Site status
Providence Alaska Medical Center Cancer Research Anchorage Alaska 99508 —
Heritage Physicians Group Oncology Hot Springs Arkansas 71913 —
The Center for Chest Care Springdale Arkansas 72764 —
Pacific Cancer Medical Center, Inc. Anaheim California 92801 —
South Bay Oncology Hematology Partners Campbell California 95008 —
Bay Area Cancer Research Concord California 94520 —
Pacific Coast Hem/Onc Fountain Valley California 92708 —
Wilshire Oncology Medical Group La Verne California 91750 —
Kenmar Research Institute Los Angeles California 90057 —
North Valley Hematology/Oncology Providence Holy Cross Medical Northridge California 91328 —
Medical Oncology Care Associates Orange California 92868 —
Ventura County Hematology and Oncology Oxnard California 93030 —
The Office of Dr. Swarna Chanduri, MD Pomona California 91767 —
Access Clinical Research Rancho Mirage California 92270 —
Cancer and Blood of the Desert Rancho Mirage California 92270 —
University of California Davis Cancer Center Sacramento California 95817 —
University of California at Los Angeles Sylmar California 91342 —
Denver Health Medical Center CACZ885M2301 Denver Colorado 80204-4507 —
Eastern Connecticut Hematology & Oncology Associates Norwich Connecticut 06360 —
Georgetown University/Lombardi Cancer Center Washington D.C. District of Columbia 20007-2197 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Baptist Cancer Center Jacksonville Florida 32209 —
Pasco Hernando Oncology New Port Richey Florida 34652 —
The Office of Dr. Elizabeth Tan-Chiu, MD PA Planatation Florida 33324 —
Suburban Hematology-Oncology Lawrenceville Georgia 30045 —
NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Chicago Illinois 60611 —
Evanston Northwestern Healthcare Medical Group Evanston Illinois 60201 —
Edward Cancer Center Naperville Illinois 60540 —
Midwest Cancer Research Group Skokie Illinois 60077 —
Investigative Clinical Research Indianapolis Indiana 46254 —
Cancer Care Center New Albany Indiana 47150 —
Associated Physicians & Surgeons Clinic Terre Haute Indiana 47804 —
Medical Associates Clinic, PC Dubuque Iowa 52001 —
University of Iowa Health Care Iowa City Iowa 52242-1091 —
Siouxland Hematology-Oncology Associates LLP Sioux City Iowa 51101 —
Cotton O'Neil Oncology Clinic Topeka Kansas 66606 —
Cancer Center of Kansas Witchita Kansas 67214-3728 —
Kentucky Lung Clinic & Kentucky Sleep Clinic Hazard Kentucky 41701 —
Lexington Oncology Associates Lexington Kentucky 40503 —
Cabrini Center for Cancer Care Alexandria Louisiana 71301 —
Southwest Oncology Associates Ltd. Lafayette Louisiana 70503 —
Greenbaum Cancer Center Baltimore Maryland 21201-1595 —
St. Agnes Hospital Baltimore Maryland 21229 —
The Harry and Jeanette Weinberg Cancer Institute at Franklin Baltimore Maryland 21237 —
Center for Cancer & Blood Disorders Bethesda Maryland 20817 —
Frederick Memorial Hospital Frederick Maryland 21701 —
Caritas Holy Family Hospital Methuen Massachusetts 01844 —
University of Michigan Clinical Trials Office Ann Arbor Michigan 48109 —
Wayne State University Detroit Michigan 48201 —
Henry Ford Hospital Oncology Detroit Michigan 48202 —
Oncology Care Associates, PLLC Saint Joseph Michigan 49085 —
St. Luke's Hospital and Health Network Duluth Minnesota 55805 —
Fairview Clinical Trial Services Minneapolis Minnesota 55414 —
Univ. of Minnesota Cancer Center 420 Delaware St. Minneapolis Minnesota 55455 —
Hubert H. Humphrey Cancer Center Robbinsdale Minnesota 55422 —
Jackson Oncology Associates Jackson Mississippi 39202 —
Capitol Comprehensive Cancer Care Clinic Jefferson City Missouri 65109 —
The Center for Cancer Care and Research St Louis Missouri 63141 —
Nebraska Hematology-Oncology PC Lincoln Nebraska 68506 —
Nevada Cancer Centers 2851 North Tenaya Way Las Vegas Nevada 89109 —
Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003 —
Saint Barnabas Medical Center Livingston New Jersey 07039 —
Somerset Hematology Oncology Associates Somerset New Jersey 08873 —
Advanced Oncology Associates Armonk New York 10504 —
Arena Oncology Associates, PC Great Neck New York 11021 —
Benedictine Hospital Kingston New York 12401 —
Beth Israel Medical Center New York New York 10003 —
Columbia Presbyterian Medical Center New York New York 10032 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Jmaes P. Wilmot Cancer Center Rochester New York 14642 —
Alamance Regional Medical Cancer Center Burlington North Carolina 27215 —
Northeast Oncology Associates Suite 250 Concord North Carolina 28025 —
Barberton Citizens Hospital Barberton Ohio 44203 —
Gabrail Cancer Center Canton Ohio 44718 —
Ohio Cancer Specialists Mansfield Ohio 44907 —
Hematology/Oncology Consultants Inc. West Worthington Ohio 43235 —
Trilogy Cancer Care Wooster Ohio 44691 —
Bay Area Hospital - Pharmacy Coos Bay Oregon 97420 —
The Corvallis Clinic, P.C. Corvallis Oregon 97330 —
Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
Lancaster Cancer Center Lancaster Pennsylvania 17601 —
U of Pittsburgh Cancer Institute Magee-Womens Hospital Pittsburgh Pennsylvania 15213 —
Guthrie Cancer Center Sayre Pennsylvania 18840 —
Mainline Oncology Hematology Assoc. Wynnewood Pennsylvania 19096 —
M. Francisco Gonzalez, MD., FACP Columbia South Carolina 29203 —
Santee Hematology/Oncology Sumter South Carolina 29150 —
MD Anderson Cancer Center/University of Texas 1155 Herman Pressler Street Houston Texas 77031 —
Cancer Centers of South Texas San Antonio Texas 78229 —
Providence Everett Medical Clinic Everett Washington 98201 —
Seattle Cancer Care Alliance Seattle Cancer Care Alliance Seattle Washington 98109 —
Rockwood Clinic Rockwood Clinic, PS Spokane Washington 99202 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00320710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00320710 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →